Abstract Body

Among persons at high risk to acquire HIV, oral PrEP has been shown to be effective, with good adherence the infection risk being reduced with 70% or more. Based on these studies PrEP is now recommended for people at substantial risk to acquire HIV. Preventing HIV among high incidence groups will potentially also have a significant impact on onward HIV transmission to sexual ( and needle sharing) partners. In most high income countries the majority of newly diagnosed HIV infections are among MSM. In some countries there is evidence of a declining incidence in this group due to earlier HIV detection and immediate ART initiation. Modelling studies show that providing PrEP to MSM at highest risk will have a significant additional impact on the HIV incidence by the combined effect of averting HIV among high risk MSM taking PrEP and the prevention of onward sexual transmission to others, estimates ranging from 15-60% reduction. A lowering impact of PrEP on the HIV incidence can also be expected among injecting drug users (IDUs). In this group PrEP should be combined with other prevention measures (needle exchange, early detection of HIV infection and immediate ART initiation) and embedded within a social and medical care program. Heterosexual migrants from high endemic countries are eligible for PrEP on an individual basis but molecular studies indicate that onward HIV transmission to others is limited so the overall impact on the HIV incidence will be low. In high endemic countries PrEP can be an additional individual tool to reduce HIV incidence in high incidence key populations like young women, sex workers and MSM. Rolling out PrEP programs in high endemic countries should be carefully balanced against and/or offered in combination with other effective interventions especially early HIV detection followed by immediate treatment. PrEP implementation requires a medical infrastructure to uninterrupted deliver PrEP with regular health checks. Investigating novel options to deliver PrEP (e.g. injectable), to circumvent problems of adherence/delivery will be beneficial. To evaluate the impact of PrEP on the HIV incidence in real world settings it is essential to set up monitoring programs to see whether those at highest risk are adequately being reached.